News Releases

Date	Title
04/12/21	Optinose to Present at the Needham Virtual Healthcare Conference
03/03/21	Optinose Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
02/17/21	Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
01/25/21	Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jonathan Neely
VP Investor Relations and Business Operations
Email: investors@optinose.com

Keyword Search